Jakimovski, Dejan http://orcid.org/0000-0001-7114-4958
Kavak, Katelyn S.
Coyle, Patricia K.
Goodman, Andrew D.
Gottesman, Malcolm
Zivadinov, Robert
Weinstock-Guttman, Bianca
,
Funding for this research was provided by:
Novartis (CBAF312AUS13T)
Article History
Received: 7 July 2023
Revised: 1 October 2023
Accepted: 3 November 2023
First Online: 23 November 2023
Declarations
:
: Katelyn S. Kavak, Andrew D Goodman and Malcolm Gottesman have nothing to disclose. Dejan Jakimovski serves as Associate Editor of Clinical Neurology and Neurosurgery and compensated by Elsevier B.V. Robert Zivadinov has received personal compensation from Bristol Myers Squibb, EMD Serono, Sanofi, Janssen, 415 Capital, Mapi Pharma, and Novartis for speaking and consultant fees. He received financial support for research activities from Sanofi, Novartis, Bristol Myers Squibb, Octave, Mapi Pharma, CorEvitas, Protembis and V-WAVE Medical. Patricia Coyle has received consultant and/or speaker fees from Accordant, Biogen, Bristol Myers Squibb, Celgene, Eli Lilly and Company, GlaxoSmithKline, Horizon Therapeutics, Janssen, LabCorp, Mylan, Novartis, Sanofi Genzyme, TG Therapeutics, Viela Bio. Dr. Coyle has also received grant/research support from Actelion, Alkermes, Celgene, CorEvitas LLC, Genentech/Roche, Janssen, MedDay, NINDS, Novartis, Sanofi Genzyme. Bianca Weinstock-Guttman received honoraria as a speaker and/or as a consultant for Biogen Idec, Teva Pharmaceuticals, EMD Serono, Genzyme, Sanofi, Genentech, Novartis, Celgene/BMS, Janssen and Horizon Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genzyme, Genentech, Sanofi, Novartis.
: All procedures performed in this study were in accordance with the ethical standards of the institutional research board (IRB) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study was approved by the University at Buffalo IRB and all participants provided a written consent form.